Predict your next investment

Venture Capital
mtip.ch

See what CB Insights has to offer

Investments

14

Portfolio Exits

1

Funds

2

About MTIP

MTIP is a Swiss-based growth investor that specializes in scaling up health tech companies in rapidly expanding global markets. The firm invests in digitally-connected, decentralized, and patient-centric medical technology leaders, based primarily in Europe, with offerings that provide clear health-related economic benefits. Its entrepreneurial investment team, which has complementary private equity skills and exceptional deal-making capabilities, actively works with portfolio companies to boost growth. MTIP efficiently deploys capital to unlock value and generate attractive returns for our investors.

MTIP Headquarter Location

Dufourstrasse 49

Basel, 4052,

Switzerland

+41 61 551 02 50

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest MTIP News

Notizie da: MTIP, Onex Corporation, Providence Equity Partners, PineBridge Investments, Carlyle Group, Norwest Venture Partners, Inflexion, Permira

Dec 8, 2021

MTIP, la società di private equity svizzera focalizzata sulla salute, ha annunciato oggi la chiusura del suo MTIP Fund II, SCSp (“Il fondo”) a 250 milioni di dollari in impegni di capitale. Si veda qui il comunicato stampa.  Il fondo sovrascritto, che ha chiuso al di sopra del suo obiettivo di 225 milioni di dollari, […]

MTIP Investments

14 Investments

MTIP has made 14 investments. Their latest investment was in Mediktor as part of their Series B on October 10, 2021.

CBI Logo

MTIP Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/4/2021

Series B

Mediktor

$12.79M

Yes

2

9/1/2021

Series C

Oviva

$80M

No

16

8/10/2021

Series A

Intelligencia.ai

$12M

Yes

13

5/19/2021

Series B

Subscribe to see more

$99M

Subscribe to see more

10

2/9/2021

Series A - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/4/2021

9/1/2021

8/10/2021

5/19/2021

2/9/2021

Round

Series B

Series C

Series A

Series B

Series A - II

Company

Mediktor

Oviva

Intelligencia.ai

Subscribe to see more

Subscribe to see more

Amount

$12.79M

$80M

$12M

$99M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

16

13

10

10

MTIP Portfolio Exits

1 Portfolio Exit

MTIP has 1 portfolio exit. Their latest portfolio exit was Blueprint Genetics on January 22, 2020.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

1/22/2020

Acquired

1

Date

1/22/2020

Exit

Acquired

Companies

Valuation

Acquirer

Sources

1

MTIP Fund History

2 Fund Histories

MTIP has 2 funds, including MTIP Fund II.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/7/2021

MTIP Fund II

$250M

2

4/4/2017

MedTech Innovation Partners Fund I

$99M

10

Closing Date

12/7/2021

4/4/2017

Fund

MTIP Fund II

MedTech Innovation Partners Fund I

Fund Type

Status

Amount

$250M

$99M

Sources

2

10

MTIP Team

3 Team Members

MTIP has 3 team members, including current Founding Partner, Felix Grisard.

Name

Work History

Title

Status

Felix Grisard

Founding Partner

Current

Hans-Florian Zeilhofer

Founding Partner

Current

Christoph Kausch

Managing Partner

Current

Name

Felix Grisard

Hans-Florian Zeilhofer

Christoph Kausch

Work History

Title

Founding Partner

Founding Partner

Managing Partner

Status

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.